Focus Financial Partners (NASDAQ:FOCS) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.91 by 8.79 percent. This is a 5.32 percent increase over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $547.68 million which beat the analyst consensus estimate of $516.79 million by 5.98 percent. This is a 4.54 percent increase over sales of $523.89 million the same period last year.
Ionis Announced Saturday: Completion Of Enrollment And Preliminary Findings From Part 1 Of The Ongoing Halos Phase 1/2a Study Of ION582 (BIIB121) In Angelman Syndrome
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced the completion of enrollment and positive preliminary findings from Part 1 of the ongoing HALOS Phase 1/2a study of ION582 (BIIB121) in Angelman syndrome. ION582
